These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
889 related articles for article (PubMed ID: 31926173)
1. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome. Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ; Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173 [TBL] [Abstract][Full Text] [Related]
2. Yield of Lynch Syndrome Surveillance for Patients With Pathogenic Variants in DNA Mismatch Repair Genes. Goverde A; Eikenboom EL; Viskil EL; Bruno MJ; Doukas M; Dinjens WNM; Dubbink EJ; van den Ouweland AMW; Hofstra RMW; Wagner A; Spaander MCW Clin Gastroenterol Hepatol; 2020 May; 18(5):1112-1120.e1. PubMed ID: 31470178 [TBL] [Abstract][Full Text] [Related]
3. Routine Molecular Analysis for Lynch Syndrome Among Adenomas or Colorectal Cancer Within a National Screening Program. Goverde A; Wagner A; Bruno MJ; Hofstra RMW; Doukas M; van der Weiden MM; Dubbink HJ; Dinjens WNM; Spaander MCW Gastroenterology; 2018 Nov; 155(5):1410-1415. PubMed ID: 30063919 [TBL] [Abstract][Full Text] [Related]
4. Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome. Schneider NB; Pastor T; Paula AE; Achatz MI; Santos ÂRD; Vianna FSL; Rosset C; Pinheiro M; Ashton-Prolla P; Moreira MÂM; Palmero EI; Cancer Med; 2018 May; 7(5):2078-2088. PubMed ID: 29575718 [TBL] [Abstract][Full Text] [Related]
5. Identification of Lynch syndrome risk variants in the Romanian population. Iordache PD; Mates D; Gunnarsson B; Eggertsson HP; Sulem P; Benonisdottir S; Csiki IE; Rascu S; Radavoi D; Ursu R; Staicu C; Calota V; Voinoiu A; Jinga M; Rosoga G; Danau R; Sima SC; Badescu D; Suciu N; Radoi V; Mates IN; Dobra M; Nicolae C; Kristjansdottir S; Jonasson JG; Manolescu A; Arnadottir G; Jensson B; Jonasdottir A; Sigurdsson A; le Roux L; Johannsdottir H; Rafnar T; Halldorsson BV; Jinga V; Stefansson K J Cell Mol Med; 2018 Dec; 22(12):6068-6076. PubMed ID: 30324682 [TBL] [Abstract][Full Text] [Related]
6. First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome. Ziada-Bouchaar H; Sifi K; Filali T; Hammada T; Satta D; Abadi N Fam Cancer; 2017 Jan; 16(1):57-66. PubMed ID: 27468915 [TBL] [Abstract][Full Text] [Related]
7. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population. Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186 [TBL] [Abstract][Full Text] [Related]
8. Molecular Background of Colorectal Tumors From Patients With Lynch Syndrome Associated With Germline Variants in PMS2. Ten Broeke SW; van Bavel TC; Jansen AML; Gómez-García E; Hes FJ; van Hest LP; Letteboer TGW; Olderode-Berends MJW; Ruano D; Spruijt L; Suerink M; Tops CM; van Eijk R; Morreau H; van Wezel T; Nielsen M Gastroenterology; 2018 Sep; 155(3):844-851. PubMed ID: 29758216 [TBL] [Abstract][Full Text] [Related]
9. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome. Berginc G; Bracko M; Ravnik-Glavac M; Glavac D Fam Cancer; 2009; 8(4):421-9. PubMed ID: 19526325 [TBL] [Abstract][Full Text] [Related]
10. Gene-Specific Variation in Colorectal Cancer Surveillance Strategies for Lynch Syndrome. Kastrinos F; Ingram MA; Silver ER; Oh A; Laszkowska M; Rustgi AK; Hur C Gastroenterology; 2021 Aug; 161(2):453-462.e15. PubMed ID: 33839100 [TBL] [Abstract][Full Text] [Related]
11. [Genetic analysis of 45 patients with suspected Lynch syndrome using next-generation sequencing]. Yao ZG; Cheng XK; Lin CH; Li J; Lyu BB; Li JM; Jing HY; Qin YJ; Sun XC Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):843-849. PubMed ID: 34407589 [No Abstract] [Full Text] [Related]
12. Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies. Ryan NAJ; Morris J; Green K; Lalloo F; Woodward ER; Hill J; Crosbie EJ; Evans DG JAMA Oncol; 2017 Dec; 3(12):1702-1706. PubMed ID: 28772289 [TBL] [Abstract][Full Text] [Related]
14. Associations Between Mutations in MSH6 and PMS2 and Risk of Surveillance-detected Colorectal Cancer. Lamba M; Wakeman C; Ebel R; Hamilton S; Frampton C; Kiesanowski M; Griffiths B; Keating J; Parry S; Chalmers-Watson T Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2768-2774. PubMed ID: 32240831 [TBL] [Abstract][Full Text] [Related]
15. Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome. Bouvet D; Bodo S; Munier A; Guillerm E; Bertrand R; Colas C; Duval A; Coulet F; Muleris M Gastroenterology; 2019 Aug; 157(2):421-431. PubMed ID: 30998989 [TBL] [Abstract][Full Text] [Related]
16. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016 [TBL] [Abstract][Full Text] [Related]
17. The First Molecular Screening of MLH1 and MSH2 Genes in Moroccan Colorectal Cancer Patients Shows a Relatively High Mutational Prevalence. Moufid FZ; Bouguenouch L; El Bouchikhi I; Chbani L; Iraqui Houssaini M; Sekal M; Belhassan K; Bennani B; Ouldim K Genet Test Mol Biomarkers; 2018 Aug; 22(8):492-497. PubMed ID: 30044143 [TBL] [Abstract][Full Text] [Related]
18. Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. Gargiulo S; Torrini M; Ollila S; Nasti S; Pastorino L; Cusano R; Bonelli L; Battistuzzi L; Mastracci L; Bruno W; Savarino V; Sciallero S; Borgonovo G; Nyström M; Bianchi-Scarrà G; Mareni C; Ghiorzo P Fam Cancer; 2009; 8(4):547-53. PubMed ID: 19728162 [TBL] [Abstract][Full Text] [Related]
19. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations. Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128 [TBL] [Abstract][Full Text] [Related]
20. Multigene Panel Testing Provides a New Perspective on Lynch Syndrome. Espenschied CR; LaDuca H; Li S; McFarland R; Gau CL; Hampel H J Clin Oncol; 2017 Aug; 35(22):2568-2575. PubMed ID: 28514183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]